nikethamide has been researched along with Cancer of Esophagus in 1 studies
Nikethamide: A central nervous system stimulant. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1229)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muiesan, G | 1 |
| Sorbini, CA | 1 |
| Grassi, V | 1 |
| Solinas, E | 1 |
| Casucci, G | 1 |
| Petz, E | 1 |
| Motolese, M | 1 |
1 trial available for nikethamide and Cancer of Esophagus
| Article | Year |
|---|---|
A controlled study of three respiratory stimulants in chronic respiratory failure.
Topics: Aminobutyrates; Carbon Dioxide; Central Nervous System Stimulants; Clinical Trials as Topic; Esophag | 1969 |